|
1
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kai K, Arima Y, Kamiya T and Saya H:
Breast cancer stem cells. Breast Cancer. 17:80–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calcagno AM, Salcido CD, Gillet JP, Wu CP,
Fostel JM, Mumau MD, Gottesman MM, Varticovski L and Ambudkar SV:
Prolonged drug selection of breast cancer cells and enrichment of
cancer stem cell characteristics. J Natl Cancer Inst.
102:1637–1652. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Du B, Qian M, Zhou Z, Wang P, Wang L,
Zhang X, Wu M, Zhang P and Mei B: In vitro panning of a targeting
peptide to hepatocarcinoma from a phage display peptide library.
Biochem Biophys Res Commun. 342:956–962. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gangopadhyay S, Nandy A, Hor P and
Mukhopadhyay A: Breast cancer stem cells: A novel therapeutic
target. Clin Breast Cancer. 13:7–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J, Zeng W, Huang Y, Zhang Q, Hu P,
Rabkin SD and Liu R: Treatment of breast cancer stem cells with
oncolytic herpes simplex virus. Cancer Gene Ther. 19:707–714. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simões BM, Piva M, Iriondo O, Comaills V,
López-Ruiz JA, Zabalza I, Mieza JA, Acinas O and Vivanco MD:
Effects of estrogen on the proportion of stem cells in the breast.
Breast Cancer Res Treat. 129:23–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zielske SP, Spalding AC, Wicha MS and
Lawrence TS: Ablation of breast cancer stem cells with radiation.
Transl Oncol. 4:227–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Driessens G, Beck B, Caauwe A, Simons BD
and Blanpain C: Defining the mode of tumour growth by clonal
analysis. Nature. 488:527–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schepers AG, Hugo HJ, Stange DE, van den
Born M, van Es JH, van de Wetering M and Clevers H: Lineage tracing
reveals Lgr5+ stem cell activity in mouse intestinal
adenomas. Science. 337:730–735. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lou H and Dean M: Targeted therapy for
cancer stem cells: The patched pathway and ABC transporters.
Oncogene. 26:1357–1360. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoogenboom HR and Chames P: Natural and
designer binding sites made by phage display technology. Immunol
Today. 21:371–378. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo AJ and Cai XP: Application of
filamentous phage display technology in parasitology. Zhongguo Ji
Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 24:304–308. 2006.(In
Chinese). PubMed/NCBI
|
|
16
|
Yip YL and Ward RL: Application of phage
display technology to cancer research. Currt Pharm Biotechnol.
3:29–43. 2002. View Article : Google Scholar
|
|
17
|
Gur D, Liu S, Shukla A, Pero SC, Wicha MS
and Krag DN: Identification of single chain antibodies to breast
cancer stem cells using phage display. Biotechnol Prog.
25:1780–1787. 2009.PubMed/NCBI
|
|
18
|
Staquicini FI, Sidman RL, Arap W and
Pasqualini R: Phage display technology for stem cell delivery and
systemic therapy. Adv Drug Deliv Rev. 62:1213–1216. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J, Zhang C, Liu G, Liu H, Zhou C, Lu
Y, Zhou C, Yuan L and Li X: A novel mouse CD133 binding-peptide
screened by phage display inhibits cancer cell motility in vitro.
Clin Exp Metastasis. 29:185–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian PG, Zhou CP, Zhang C, Yang H, Wu XJ,
Lu YX, Liu GB and Li XN: Selection and identification of specific
binding peptides for cancer stem cell surface marker CD133. Nan
Fang Yi Ke Da Xue Xue Bao. 31:761–766. 2011.(In Chinese).
PubMed/NCBI
|
|
21
|
Yang W, Luo D, Wang S, Wang R, Chen R, Liu
Y, Zhu T, Ma X, Liu R, Xu G, et al: TMTP1, a novel tumor-homing
peptide specifically targeting metastasis. Clin Cancer Res.
14:5494–5502. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu ZZ, Chen P, Lu ZD, Cui SD and Dong ZM:
Enrichment of breast cancer stem cells using a keratinocyte
serum-free medium. Chin Med J (Engl). 124:2934–2936.
2011.PubMed/NCBI
|
